Disclosure Of Revenue From Contracts With Customers [Text Block]

Innate Pharma - Filing #5981200

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of revenue from contracts with customers [text block]
Contract liabilities [abstract]
Non-current contract liabilities
2 825 EUR
4 618 EUR
Current contract liabilities
616,000 EUR
5 865 EUR
Revenue from contracts with customers
12 622 EUR
51 901 EUR
Disclosure of disaggregation of revenue from contracts with customers [text block]
Disclosure of disaggregation of revenue from contracts with customers [abstract]
Disclosure of disaggregation of revenue from contracts with customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.